Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March 31st, 2022.
Q4FY22 performance overview compared with Q3FY22 &n... (more)
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced a calibrated restart of manufacturing operations in plants located at Mahad, Dist. Raigad. The Company managed to resume operations in units situated in Chiplun within... (more)
Lasa Supergenerics Limited (BSE: 540702, NSE: LASA), pioneer and amongst the leading players in the manufacturing of Veterinary and Human APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has added another product - Oxyclozanide to its portfolio of products.... (more)
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March 31, 2021.
FY21 Performance overview compared with FY20
Rev... (more)
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31st 2020 (Q3FY21).
Q3FY21 performance overview compared with Q3FY20
The Fi... (more)
API major, Lasa Supergenerics Ltd. Received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration authorities for its manufacturing facility situated at Khed (Ratnagiri).
Commenting on the development, Dr. Omkar Herlekar, Chairman - Lasa Superg... (more)
